Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACER: Cetuximab and Radiotherapy in Locally Advanced Pancreatic Cancer
NCT00599833Phase 2Completed
- Sponsor
- The Christie
- Start
- May 2007
- Primary completion
- Sep 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in pancreatic adenocarcinoma (PDAC), sponsored by The Christie. Started May 2007; status: completed.
02
Drugs
cetuximab
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00599833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599833.